Method for treating cancer
US10786511B2 · kind B2 · utility
5Cited by
10References
20Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 17, 2015 |
| Grant date | Sep 29, 2020 |
| Priority date | — |
| Expiry date | Dec 11, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/2004
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to pharmaceutical compositions comprising inhibitor(s) of human histone methyltransferase EZH2, and methods of cancer therapy using the EZH2 inhibitor(s).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.